Pfizer hopes that vaccinations of the group could begin before the next school year, Albert Bourla, Pfizer’s chairman and chief executive, said in a statement.
In the trial of 2,260 adolescents aged 12 to 15, there were 18 cases of COVID-19 in the group that got a placebo shot and none in the group that got the vaccine, resulting in 100% efficacy in preventing COVID-19, the companies said in a statement. The companies also studied a subset of teens to measure the level of virus-neutralizing antibodies a month after the second dose and found it was comparable to study participants aged 16 to 25 in the pivotal trial in adults.
An adolescents immune system is equally as effective.. and much safer.
AAPI genetics small and weak. We need more money from America government to pay Asian hate groups
Good!
My encounter with miss Amelia markdonald actually changed my life and for that I’ll keep upgrading people for he's good job thanks once again AMELIMARKD
We dont need emergency use in 12-15 year olds.
Hope they show us the study and not just the press release. Was this a purely in-house study?
Absolutely nothing to do with the stocks and shares falling?